As of Mar 04th, 2025, there has been substantial selling of Neumora Therapeutics, Inc. in recent trading

The chart below shows ALL of the short selling each day in NEUMORA THERAPEUTICS, INC. (NMRA). We have consolidated the tape of ALL US stock exchanges and dark pools (this means we get the TRADE IDENTIFIER showing whether the trade was a buy, sell or sell short). The data below shows just the short sales each day in your stock. It includes both EXEMPT (market makers) and NON-EXEMPT (everyone else) short sales in NEUMORA THERAPEUTICS, INC.. An average of 47.06% of the daily trading in NMRA is short selling. This is abnormally high and implies there is illicit trading taking place in your stock. We run automated surveillance and reporting algorithms that report manipulative market making and short selling (to FINRA, SEC, Whistleblower's Office and Dept of Treasury FINCEN). We then issue FINRA COMPLIANT research to our large user base to counteract this activity that is driving NMRA lower unfairly.

You can find the full report at [ https://www.woprai.com/ ]

Please find the applicable data below, drawn from all major market providers.

Date	Short Volume	Total Volume	Percentage	Squeeze Trigger	$ Value
2025-03-03	670,358	1,453,690	46.11	1.47	985,426
2025-02-28	932,163	1,957,528	47.62	1.56	1,454,174
2025-02-27	316,089	559,143	56.53	1.59	502,582
2025-02-26	495,969	735,965	67.39	1.65	818,349
2025-02-25	871,117	1,261,091	69.08	1.65	1,437,343
2025-02-24	766,081	1,121,779	68.29	1.73	1,325,320
2025-02-21	1,252,488	2,133,769	58.7	1.77	2,216,904
2025-02-20	965,215	1,449,577	66.59	1.68	1,621,561
2025-02-19	953,236	1,536,393	62.04	1.65	1,572,839
2025-02-18	1,479,403	2,287,551	64.67	1.72	2,544,573
2025-02-14	765,458	1,190,099	64.32	1.74	1,331,897
2025-02-13	1,036,040	1,580,220	65.56	1.66	1,719,826
2025-02-12	1,436,655	2,125,736	67.58	1.67	2,399,214
2025-02-11	1,104,854	1,668,372	66.22	1.69	1,867,203
2025-02-10	1,588,174	2,788,109	56.96	1.78	2,826,950
2025-02-07	665,433	1,189,636	55.94	1.87	1,244,360
2025-02-06	455,261	773,682	58.84	1.95	887,759
2025-02-05	621,289	1,534,328	40.49	1.94	1,205,301
2025-02-04	823,010	1,893,808	43.46	1.91	1,571,949
2025-02-03	1,280,672	2,066,424	61.98	1.86	2,382,050
2025-01-31	924,756	1,710,155	54.07	1.96	1,812,522
2025-01-30	1,132,714	2,159,473	52.45	1.94	2,197,465
2025-01-29	1,102,775	1,946,485	56.65	1.92	2,117,328
2025-01-28	1,719,297	3,093,846	55.57	1.95	3,352,629
2025-01-27	1,311,378	2,843,733	46.11	2.06	2,701,439
2025-01-24	1,674,251	3,226,426	51.89	2.12	3,549,412
2025-01-23	2,249,023	4,459,116	50.44	2.05	4,610,497
2025-01-22	1,082,306	2,785,867	38.85	2.11	2,283,666
2025-01-21	1,320,105	3,574,801	36.93	2.07	2,732,617
2025-01-17	2,571,676	4,642,116	55.4	2.06	5,297,653
2025-01-16	1,137,159	2,215,387	51.33	2.16	2,456,263
2025-01-15	1,227,933	2,758,393	44.52	2.2	2,701,453
2025-01-14	1,490,426	3,594,981	41.46	2.24	3,338,554
2025-01-13	1,387,865	4,133,523	33.58	2.31	3,205,968
2025-01-10	1,840,148	4,985,718	36.91	2.2	4,048,326
2025-01-08	2,203,618	5,558,310	39.65	2.37	5,222,575
2025-01-07	3,212,568	7,976,877	40.27	2.67	8,577,557

Total	178,354,286	377,534,496	47.24	7.89	1,406,437,891

* Totals include all data records back to 2023-09-19 00:00:00, data set is truncated for viewing.

N@N

As of Mar 04th, 2025, there has been substantial selling of Neumora Therapeutics, Inc. in recent trading